Male population with low sexual desire treated with an association of testosterone (intramuscular) and transdermal testosterone gel

Dr Carlos Moreira

Replacement treatment with Testosterone has been a controversial issue along the last 5 years. Despite the average good response to treatment many scientist disagree with the  proposal of giving Testosterone on the bases of clinical evidence of Low Sexual Desire without dosage of Testosterone blood level. Our objectives were to treat an adult male population (n=200) which presented Low Sexual Desire with intramuscular (Duratestone, Lilly) and transdermal fixed doses of Testosterone (Androlone gel, Beta).

 

Conflict of Interest: None disclosed
Financial Support/Funding:
None disclosed
Recorded at 19th WAS World Congress for Sexual Health - Sexual Health & Rights: A Global Challenge Göteborg (Sweden) - June 21 – 25, 2009

Carlos Moreira
Carlos  Moreira
  more about this speaker

WAS
XShare
Click on a link above to share this page with your networking site.

Media     

TITLE SPEAKER DURATION
VideoMale population with low sexual desire treated with an association of testosterone (intramuscular) and transdermal testosterone gelCarlos Moreira8'07"
icon pdf.gifMale population with low sexual desire treated with an association of testosterone (intramuscular) and transdermal testosterone gel Carlos Moreira 
icon mp3.gifMale population with low sexual desire treated with an association of testosterone (intramuscular) and transdermal testosterone gel Carlos Moreira 


Top of page

Dr Carlos Moreira

Director, Clínica Masters, Montevideo, Uruguay.

Top of page
Subscribers
Login Here
Email
Password
Subscribe
Now
BENEFIT from
UNLIMITED ACCESS to our
GROWING VIDEO LIBRARY
 
 
 
$19.95 - Unlimited Access
 
 
 
$99.75 - Save 1 Month
 
 
 
$149.95 - Save 3 Months
WAS - World Association fro Sexual HealthSociety of Australian SexologiestsAustralian Centre for Sexual HealthashnAOFSCSEPI - Council of Sex Education and Parenthood (International)SASSM